Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 Bekeken
• 07/14/23
0
0
insluiten
administrator
abonnees
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties